FORA Capital’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-27,120
Closed -$1.43M – 544
2026
Q1
$1.43M Sell
27,120
-6,608
-20% -$271K 0.1% 196
2025
Q4
$1.36M Buy
+33,728
New +$779K 0.16% 166

Other funds holding TERN

FORA Capital's TERN Position: Q2 2026 in Review

FORA Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 27,120 shares — an estimated $1.43M sold.

FORA Capital first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $1.43M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • FORA Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • FORA Capital sold 27,120 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.43M.
  • FORA Capital first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • FORA Capital's Terns Pharmaceuticals position peaked at $1.43M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.